Melissa Epperly - 17 Apr 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
Issuer symbol
ROIV
Transactions as of
17 Apr 2025
Transactions value $
$0
Form type
4
Filing time
21 Apr 2025, 21:00:24 UTC
Previous filing
27 Jan 2025
Next filing
25 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +1,847 +4.7% $0 41,376 17 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.